• Investor
    Resources
  • Press
    Releases
  • Financial Reports
    and Filings
    Financial Reports SEC Filings SEDAR® Filings Stock Information Interactive Chart
  • Corporate
    Governance
  • Webcasts
  • Investor
    Briefcase
    Investor Briefcase Frequently Asked
    Questions
  • Subscribe

Corporate
Governance

  •   >
  • Corporate
    Governance
  • Mandat du Comité des RH et de gouvernance d'entreprise 2021
  • HR & Corporate Governance Committee Charter 2021
  • Mandat du Comité d'audit, de gestion des risques et des finances 2021
  • Audit, Risk and Finance Committee Charter
  • Liminal BioSciences Articles of Incorporation 2019
  • Code of Ethics and Business Conduct 2021
  • Majority Voting Policy 2021
  • Board of Directors Charter 2021
  • Board Committees: Chair Mandate 2021
  • CEO Position Description 2021
  • Mandate of the Chair of the Board of Directors 2021
  • Position Description for the Lead Independent Director of the Board of Directors 2021
  • By-Law No.3
  • By-Law No.2
  • Amendment to By-Law No.1 - June 8, 2020
  • Amendment to By-Law No.1 - May 3, 2006
  • By-Law No.1
  • Articles of Amendment - June 16, 2020
  • Certificate of Amendment - February 16, 2000
  • Certificate of Amendment - October 3, 2019
  • Certificate of Amendment - June 28, 2019
  • Certificate of Amendment - November 13, 2018
  • Certificate of Amendment - June 1, 2017
  • Certificate of Amendment - January 25, 2013
  • Certificate of Amendment - May 15, 2008
Show 5102550100 per page
  • «
  • 1
  • 2
  • »

© 2022 Liminal BioSciences Inc. All Rights Reserved. | Legal Disclaimer | Privacy Policy | Cookie Policy | Social Media Guidelines